Pathophysiologic basis for the medical management of portal hypertension

Author： Poordad Fred F   Sigal Samuel H   Brown Robert S  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.3, 2009-02, pp. : 453-467

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medical management of primary pulmonary hypertension

By McLaughlin Vallerie V  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 2, 2002-02 ,pp. : 159-165

Informa Healthcare

Access to resources Recommend Favorite

Pathophysiologic therapeutic targets in hypertension: a cardiological point of view

By Fragasso Gabriele   Maranta Francesco   Montanaro Claudia   Salerno Anna   Torlasco Camilla   Margonato Alberto  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 2, 2012-02 ,pp. : 179-193

Informa Healthcare

Access to resources Recommend Favorite

Didanosine linked to noncirrhotic portal hypertension

By  

Reactions Weekly, Vol. 1, Iss. 1287, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Tioguanine: Portal hypertension and thrombocytopenia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1249, 2009-01 ,pp. : 43-44

Adis International

Access to resources Recommend Favorite

Didanosine: Noncirrhotic portal hypertension: case report

By  

Reactions Weekly, Vol. 1, Iss. 1325, 2010-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite